Recap: Precigen Q4 Earnings
Recap: Precigen Q4 Earnings
Shares of Precigen (NASDAQ:PGEN) decreased in after-market trading after the company reported Q4 results.
Quarterly Results
Earnings per share increased 15.38% over the past year to ($0.22), which missed the estimate of ($0.17).
Revenue of $19,333,000 rose by 13.71% year over year, which beat the estimate of $16,960,000.
Outlook
Precigen hasn't issued any earnings guidance for the time being.
Precigen hasn't issued any revenue guidance for the time being.
Conference Call Details
Date: Mar 01, 2021
Time: 04:30 PM
ET Webcast URL: https://www.webcaster4.com/Webcast/Page/876/40135
Technicals
52-week high: $11.10
52-week low: $1.26
Price action over last quarter: Up 33.33%
Company Profile
Precigen Inc is a biotechnology company that develops synthetic biology solutions. The company designs, builds, and regulates gene programs. Its technologies are broadly applicable across a wide range of diverse end markets. Intrexon's business model is to commercialize its technologies through exclusive channel collaborations with collaborators that have specific industry expertise, development resources, and sales and marketing capabilities, in order to bring new and improved products and processes to market. The company's collaborators provide compensation through technology access fees, royalties, milestones, and reimbursement of certain costs.
Shares of Precigen (NASDAQ:PGEN) decreased in after-market trading after the company reported Q4 results.
的股份早孕症(纳斯达克:PGEN)在该公司公布第四季度业绩后,盘后交易减少。
Quarterly Results
季度业绩
Earnings per share increased 15.38% over the past year to ($0.22), which missed the estimate of ($0.17).
过去一年每股获利增长15.38%至0.22美元,低于预估的0.17美元。
Revenue of $19,333,000 rose by 13.71% year over year, which beat the estimate of $16,960,000.
营收为1933.3万美元,同比增长13.71%,超过预期的1696万美元。
Outlook
展望
Precigen hasn't issued any earnings guidance for the time being.
Precigen暂时没有发布任何盈利指引。
Precigen hasn't issued any revenue guidance for the time being.
Precigen暂时没有发布任何收入指引。
Conference Call Details
电话会议详细信息
Date: Mar 01, 2021
日期:2021年3月1日
Time: 04:30 PM
时间:下午4时30分
ET Webcast URL: https://www.webcaster4.com/Webcast/Page/876/40135
Technicals
技术细节
52-week high: $11.10
52周高点:11.10美元
52-week low: $1.26
52周低点:1.26美元
Price action over last quarter: Up 33.33%
上季度价格走势:上涨33.33%
Company Profile
公司简介
Precigen Inc is a biotechnology company that develops synthetic biology solutions. The company designs, builds, and regulates gene programs. Its technologies are broadly applicable across a wide range of diverse end markets. Intrexon's business model is to commercialize its technologies through exclusive channel collaborations with collaborators that have specific industry expertise, development resources, and sales and marketing capabilities, in order to bring new and improved products and processes to market. The company's collaborators provide compensation through technology access fees, royalties, milestones, and reimbursement of certain costs.
Precigen Inc是一家开发合成生物学解决方案的生物技术公司。该公司设计、构建和管理基因程序。其技术广泛适用于各种不同的终端市场。Intrexon的商业模式是通过与拥有特定行业专业知识、开发资源以及销售和营销能力的合作者进行独家渠道合作,将其技术商业化,以便将新的和改进的产品和流程推向市场。该公司的合作者通过技术访问费、版税、里程碑和某些费用的报销来提供补偿。
译文内容由第三方软件翻译。
风险及免责提示
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
使用浏览器的分享功能,分享给你的好友吧